See Janux Therapeutics Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Key Financial Ratios

Market Cap

695.16M

Dividend TTM

0.00

P/E TTM

-6.16

EPS TTM

-1.84

Revenue

10.00M

Net Profit

-68.99M

ROE

-11.72%

ROA

-11.01%

Janux Therapeutics Inc Earnings Date

Latest Release

Nov 5, 2026

EPS / Forecast

-0.34/-0.47

Revenue / Forecast

9.29M/7.75M

Financial Statement Highlights

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2026Q3

FY2026Q2

FY2026Q1

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021Q4

Financial Indicators

EPS

12.78%-0.34

36.17%-0.35

-2.18%-0.39

-44.57%-0.51

23.68%-0.39

-399.78%-0.55

-26.43%-0.38

-41.26%-0.36

-102.95%-0.51

73.85%-0.11

28.02%-0.30

34.84%-0.25

---0.25

---0.42

---0.39

---1.13

----

Revenue

-7.11%9.29M

--10.27M

--3.73M

--0.00

2177.90%10.00M

-100.00%0.00

-82.56%439.00K

741.72%8.90M

-38.87%1.25M

-13.50%2.46M

38.83%2.52M

-55.31%1.06M

28.89%2.05M

76.05%2.84M

56.43%1.81M

390.66%2.37M

318.16%1.59M

--1.62M

Net Profit

11.28%-21.57M

35.11%-21.97M

-3.63%-24.36M

-58.02%-31.95M

13.35%-24.31M

-468.18%-33.86M

-59.27%-23.51M

-71.93%-20.22M

-142.56%-28.06M

65.96%-5.96M

15.46%-14.76M

26.81%-11.76M

30.71%-11.57M

-3.67%-17.51M

-30.19%-17.46M

-19.75%-16.07M

-55.08%-16.70M

-172.12%-16.89M

-487.13%-13.41M

-710.63%-13.42M

Net Margin

4.49%-232.21%

---214.01%

---652.59%

----

96.20%-243.13%

----

-1290.70%-6391.57%

95.96%-66.98%

-38.29%-1178.91%

15.39%-477.77%

---459.59%

---1656.39%

---852.49%

---564.67%

---814.88%

----

Gross Margin

0.00%100.00%

--100.00%

----

0.00%100.00%

----

0.00%100.00%

--100.00%

----

Debt to assets ratio

----

--0.00%

----

Income Statement

Revenue

-7.11%9.29M

--10.27M

--3.73M

--0.00

2177.90%10.00M

-100.00%0.00

-82.56%439.00K

741.72%8.90M

-38.87%1.25M

-13.50%2.46M

38.83%2.52M

-55.31%1.06M

28.89%2.05M

76.05%2.84M

56.43%1.81M

390.66%2.37M

318.16%1.59M

--1.62M

Operating profit

11.33%-31.26M

29.76%-31.69M

1.96%-34.21M

-46.10%-42.40M

1.65%-35.25M

-226.42%-45.12M

-73.09%-34.90M

-79.85%-29.02M

-126.66%-35.84M

33.38%-13.82M

0.59%-20.16M

11.66%-16.14M

12.26%-15.81M

-20.20%-20.75M

-49.76%-20.28M

-35.40%-18.27M

-65.29%-18.02M

-176.09%-17.26M

-492.91%-13.54M

-715.11%-13.49M

Net Profit

11.28%-21.57M

35.11%-21.97M

-3.63%-24.36M

-58.02%-31.95M

13.35%-24.31M

-468.18%-33.86M

-59.27%-23.51M

-71.93%-20.22M

-142.56%-28.06M

65.96%-5.96M

15.46%-14.76M

26.81%-11.76M

30.71%-11.57M

-3.67%-17.51M

-30.19%-17.46M

-19.75%-16.07M

-55.08%-16.70M

-172.12%-16.89M

-487.13%-13.41M

-710.63%-13.42M

Balance Sheet

Current assets

-3.88%959.38M

-2.21%983.34M

-2.08%1.00B

-5.59%975.89M

49.79%998.09M

51.91%1.01B

55.37%1.02B

195.97%1.03B

87.59%666.32M

114.01%661.94M

104.94%658.67M

5.05%349.24M

3.16%355.19M

-13.62%309.30M

-11.86%321.40M

-11.82%332.44M

-11.62%344.33M

-9.72%358.06M

410.68%364.65M

--377.02M

Total current liabilities

94.92%54.25M

181.36%60.15M

236.62%58.91M

43.18%25.00M

62.06%27.83M

85.18%21.38M

64.97%17.50M

33.96%17.46M

18.67%17.17M

-35.52%11.54M

-34.16%10.61M

-21.05%13.03M

-11.41%14.47M

37.79%17.90M

28.76%16.11M

28.99%16.51M

30.98%16.34M

41.16%12.99M

81.53%12.52M

--12.80M

Total assets

-4.01%983.65M

-2.38%1.01B

-2.15%1.03B

-5.65%1.00B

47.44%1.02B

49.29%1.03B

52.51%1.05B

179.05%1.06B

79.66%695.02M

102.46%691.41M

95.20%688.98M

4.50%380.41M

2.95%386.85M

-11.38%341.50M

-4.24%352.96M

-4.16%364.01M

-3.92%375.76M

-2.89%385.37M

413.23%368.60M

--379.82M

Total liabilities

49.43%72.04M

91.07%79.67M

126.33%86.69M

15.51%44.74M

23.89%48.21M

23.60%41.70M

15.30%38.30M

7.42%38.73M

2.67%38.91M

-19.74%33.73M

-20.32%33.22M

-16.67%36.06M

-14.33%37.90M

1.16%42.03M

233.14%41.69M

220.59%43.27M

208.66%44.24M

245.45%41.55M

11.30%12.52M

--13.50M

Total equity

-6.65%911.61M

-6.31%927.98M

-7.01%941.53M

-6.45%956.82M

48.84%976.55M

50.61%990.52M

54.40%1.01B

197.02%1.02B

88.02%656.10M

119.61%657.68M

110.68%655.76M

7.36%344.35M

5.26%348.95M

-12.90%299.47M

-12.59%311.26M

-12.44%320.74M

-12.01%331.51M

-10.65%343.81M

487.84%356.08M

--366.33M

Cash Flow Statement

Net operating income

-95.88%-25.18M

152.43%12.48M

27.53%-12.34M

-70.65%-28.54M

-476.24%-12.86M

-137.63%-23.81M

-14.74%-17.02M

-68.92%-16.73M

80.95%-2.23M

33.43%-10.02M

-6.66%-14.84M

16.89%-9.90M

12.71%-11.71M

-147.88%-15.05M

-20.73%-13.91M

-13.66%-11.91M

-129.14%-13.41M

2.11%-6.07M

-307.12%-11.52M

-543.40%-10.48M

Net investment

362.08%38.38M

-2582.97%-38.78M

102.43%8.29M

-12.92%29.54M

-34.46%8.31M

100.82%1.56M

-199.28%-340.39M

205.01%33.93M

120.62%12.67M

-1167.95%-190.88M

-1201.33%-113.74M

793.45%11.12M

-410.94%-61.45M

97.74%17.87M

-128.13%-8.74M

-121.89%-1.60M

109.62%19.76M

106.34%9.04M

20405.88%31.07M

--7.33M

Net financing

72.82%852.00K

134.80%2.24M

539.89%3.54M

-99.24%2.94M

-70.10%493.00K

-65.50%954.00K

-99.83%554.00K

46428.28%386.65M

-97.09%1.65M

423.67%2.77M

20290.57%322.17M

335.08%831.00K

--56.61M

71.43%528.00K

157900.00%1.58M

16.46%191.00K

100.00%0.00

-99.91%308.00K

-100.00%1.00K

-96.40%164.00K

FAQs

What is the total revenue of Janux Therapeutics Inc?



According to Janux Therapeutics Inc's FY2025 earnings report, its total revenue reached 10.00M, with a year-on-year change of 10.59M.

What are the current assets of Janux Therapeutics Inc?



According to Janux Therapeutics Inc's FY2025 earnings report, its current assets were 959.38M, with a year-on-year change of -1.69.

What are the total assets of Janux Therapeutics Inc?



According to Janux Therapeutics Inc's FY2025 earnings report, its total assets of Janux Therapeutics Inc were 983.65M, with a year-on-year change of -1.79.

What are the total liabilities of Janux Therapeutics Inc?



According to Janux Therapeutics Inc's FY2025 earnings report, its total liabilities of Janux Therapeutics Inc were 72.04M, with a year-on-year change of 61.02.

What is the total equity of Janux Therapeutics Inc?



According to Janux Therapeutics Inc's FY2025 earnings report, its total equity of Janux Therapeutics Inc was 911.61M, with a year-on-year change of -4.73.

What is the net operating income of Janux Therapeutics Inc?



According to Janux Therapeutics Inc's FY2025 earnings report, its net operating income of Janux Therapeutics Inc was -157.67M, with a year-on-year change of -59.51.

What is the net investment of Janux Therapeutics Inc?



According to Janux Therapeutics Inc's FY2025 earnings report, its net investment of Janux Therapeutics Inc was -300.98M, with a year-on-year change of -16.65.

What is the net financing of Janux Therapeutics Inc?



According to Janux Therapeutics Inc's FY2025 earnings report, its net financing of Janux Therapeutics Inc was 4.95M, with a year-on-year change of -99.31.

What is the net income of Janux Therapeutics Inc?



According to Janux Therapeutics Inc's FY2025 earnings report, its net income was -113.62M, with a year-on-year change of -64.69.

What is the operating profit of Janux Therapeutics Inc?



According to Janux Therapeutics Inc's FY2025 earnings report, its operating profit was -157.67M, with a year-on-year change of -59.51.